Edetic Acid is a chemical used in medicine and food. It helps bind to certain minerals, like calcium, in the body. It's used in making medicines and sometimes in food.
Every report comes from a Lived member, sent anonymously.
Have you tried EDTA (Edetic Acid) for Lead Poisoning?
EDTA, short for ethylenediaminetetraacetic acid (also called edetic acid), is a chelating agent: a compound that latches onto certain metals in the body so the kidneys can flush them out in urine. In medicine, the form approved in the US is edetate calcium disodium, an injection used to treat lead poisoning in children and adults. That includes lead encephalopathy, the brain swelling that severe lead poisoning can cause. It was long sold under the brand name Calcium Disodium Versenate, which has been discontinued; generic versions remain available. EDTA lowers the amount of lead in the body, but it does not stop new exposure. Finding and removing the source of lead remains the core of care, and chelation is added when levels are high enough to need it. A different form, edetate disodium, has been promoted as "chelation therapy" for heart disease. EDTA chelation is not FDA approved for that use. A large NIH-funded trial published in 2024 found that 40 weekly infusions did not reduce heart attacks, strokes or other cardiovascular events in people with diabetes and a previous heart attack, compared with placebo, even though the infusions lowered blood lead. An earlier trial had suggested a benefit, but the newer one did not confirm it.
Edetate calcium disodium carries a calcium atom bound inside its structure. When it meets a metal that binds to it more tightly, such as lead, it lets go of the calcium and holds the lead instead. The resulting complex stays in the blood and the fluid around cells until the kidneys excrete it, mostly within a day. Because it swaps calcium rather than stripping it away, it does not lower blood calcium. The trade-off is that it also binds zinc, an essential mineral, so zinc levels can fall during treatment. Most of the lead it removes comes from bone, where the body stores lead over time. When a course ends, lead still in other tissues moves back into bone, so one course rarely clears the body's stores. Animal studies also suggest that a short course does not lower lead in the brain. This is why treatment is given in courses with breaks, guided by repeat blood tests.
Edetate calcium disodium is given by health professionals, usually in the hospital. It can be given as a slow intravenous (IV) drip over 8 to 12 hours each day, or as injections into a muscle spaced through the day. Muscle injections are mixed with a numbing medicine because they are otherwise painful. The dose is calculated from body size and lowered for people with reduced kidney function, and the recommended daily dose is never exceeded. A typical course lasts five days, followed by a break of two to four days. The break lets lead redistribute in the body and helps avoid running low on zinc and other essential minerals. Two courses are common, though the number depends on how severe the poisoning is and how well the person tolerates treatment. When blood lead is very high or symptoms of lead poisoning are present, EDTA is combined with dimercaprol (also called BAL), another metal-binding medicine, because EDTA alone can worsen symptoms in that situation. For anyone with lead encephalopathy, injections into the muscle are preferred, because an IV infusion can raise pressure inside an already swollen brain to a fatal degree. Before the first dose, the team makes sure the person is producing urine, often by giving IV fluids, since the drug leaves the body almost entirely through the kidneys.
Common effects include pain where a muscle injection is given, fever, chills, tiredness, muscle and joint aches, headache, nausea and loss of appetite. Some people get sneezing, a stuffy nose, watery eyes or a rash. Blood tests often show mild rises in liver enzymes, which return to normal within about two days of stopping. The most important serious risk is kidney damage, which can look like the kidney injury lead itself causes. It is more likely at higher doses. The team checks urine and kidney function before and during each course and stops treatment at the first sign of kidney injury. If urine output stops, tell the care team right away. Low blood pressure and irregular heart rhythms can occur during IV treatment, so heart monitoring is used. Zinc levels can drop, and temporary bone marrow suppression with anemia (a low red blood cell count) can occur.
Two EDTA drugs with nearly identical names have very different safety profiles. Edetate disodium, formerly sold as Endrate, has no calcium attached, so it pulls calcium out of the blood and can cause a dangerous drop. Children and adults have died when edetate disodium was given by mistake instead of edetate calcium disodium, or when it was used for unapproved chelation. The FDA withdrew approval of edetate disodium injection products in 2008. Because the two are both called "EDTA," it is reasonable to ask which one is being given. Edetate calcium disodium is not used when the kidneys have stopped making urine or in people with active kidney disease or hepatitis (liver inflammation). In animal studies, steroid medicines made its kidney toxicity worse. In pregnancy it is used only when clearly needed: there are no adequate human studies, and very high doses caused birth defects in rats, which extra zinc prevented. It is not known whether it passes into breast milk. The FDA has warned against chelation products sold for home use, such as dietary supplements, nasal sprays and suppositories marketed to remove metals. None is approved to treat any condition, and relying on them can delay proper care for lead exposure.
Treatment usually means several days in the hospital, with regular blood and urine tests to track lead levels, kidney and liver function and electrolytes. In severe cases these checks are daily; in milder cases they are done on set days during the course. Because the body stores lead in bone and moves it between tissues, follow-up blood lead tests after a course show whether another course is needed. Chelation is only one part of care. If the source of exposure stays in place, lead levels can climb again. For children, care often includes an environmental investigation of the home and steps to reduce lead hazards, coordinated by the clinician and the local health department. Children with very high levels are usually treated with input from a medical toxicologist or a pediatrician experienced in lead poisoning. Anyone considering EDTA chelation for heart disease should discuss it with a cardiologist first, since current evidence does not show that it prevents heart attacks or strokes.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking EDTA (Edetic Acid), what you've noticed, or ask the community a question.